Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice
Alpha Psychiatry · 17.08.2026 · 27 (4)
DOI: 10.31083/ap51694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alpha Psychiatry, online erschienen am 17.08.2026. Verfasst von Jieyu Ji und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Dali University, 671003 Dali, Yunnan, China. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Basic Research Program General Project, Young Scientists Fund for Basic Research of Local Universities in Yunnan Province.
Abstract (Originalsprache)
Background:Anxiety-related symptoms are frequently reported in patients with chronic myeloid leukemia (CML) receiving tyrosine kinase inhibitor (TKI) therapy. However, the role of TKIs, including imatinib, in development of anxiety remains unclear. The prefrontal cortex (PFC) is closely associated with anxiety-like behaviors, and its metabolic components, particularly lipid- and myelin-related metabolites, are involved in their regulation. Whether imatinib affects brain metabolism remains unknown. This study aimed to evaluate the effects of imatinib on anxiety-like behaviors and to investigate associated metabolic alterations in the PFC.Methods:Anxiety-like behaviors were assessed using a battery of behavioral assays in imatinib-treated mice. PFC tissues from imatinib-treated and control mice were subjected to untargeted metabolomic analysis.Results:Imatinib-treated mice exhibited selective alterations in anxiety-like behaviors. Metabolomic analysis revealed distinct metabolic profiles between the two groups, with significant changes in lipid-related pathways, particularly sphingolipid metabolism. These findings extend the current understanding of the metabolic basis of anxiety-like behaviors and suggest that TKI treatment may influence neuropsychiatric processes through metabolic remodeling of the PFC.Conclusions:This study highlights a potential link between TKI therapy and brain metabolism and provides a framework for understanding the neurobiological basis of anxiety-related effects. These findings may inform future research on the neuropsychiatric consequences of targeted cancer therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Dali University, 671003 Dali, Yunnan, China.
- School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, 47500 Subang Jaya, Selangor, Malaysia.
ORCID-Profile: Zhiting Gong
Förderung
- National Natural Science Foundation of China
- Yunnan Basic Research Program General Project
- Young Scientists Fund for Basic Research of Local Universities in Yunnan Province
- Yunnan Provincial Joint Basic Research Project for Local Undergraduate Colleges and Universities
- Dali University Undergraduate Research Fund Project
Zitieren
APA
Ji, J., Wang, Y., Qu, S., Peng, X., Ma, R., Li, H., Chang, J., Li, L., Li, Y., & Gong, Z. (2026). Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice. Alpha Psychiatry, 27(4). https://doi.org/10.31083/ap51694
Vancouver
Ji J, Wang Y, Qu S, Peng X, Ma R, Li H, et al. Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice. Alpha Psychiatry. 2026;27(4). doi:10.31083/ap51694
BibTeX
@article{Ji2026,
author = {Ji, Jieyu and Wang, You and Qu, Shanglan and Peng, Xin and Ma, Ruixue and Li, Hanwei and Chang, Jinlong and Li, Lijuan and Li, Yanjiao and Gong, Zhiting},
title = {Imatinib-Induced Changes in Anxiety-Like Behaviors are Associated With Prefrontal Cortical Metabolic Remodeling in Mice},
journal = {Alpha Psychiatry},
year = {2026},
volume = {27},
number = {4},
doi = {10.31083/ap51694}
}
EUVIMED